anti-Escherichia coli str. K-12 substr. MG1655 antibodies | find any Escherichia coli str. K-12 substr. MG1655 antibody

overview

Labome lists 954119 antibody products against 88487 genes, including 19044 human, 15677 mouse, and 14548 rat genes.

This is a summary of Escherichia coli str. K-12 substr. MG1655 antibody products in Labome database. There are 66 monoclonal Escherichia coli str. K-12 substr. MG1655 antibody products, 93 polyclonal Escherichia coli str. K-12 substr. MG1655 antibody products, 2 recombinant Escherichia coli str. K-12 substr. MG1655 antibody products.

If you are looking for antibodies against specific Escherichia coli str. K-12 substr. MG1655 gene, type in gene name in the box above and search. In the resultant gene webpage, select the correct species and 'antibody' link to go to the antibody webpage.

Clonality

Labome product database lists 66 monoclonal anti-Escherichia coli str. K-12 substr. MG1655 antibodies, 93 polyclonal anti-Escherichia coli str. K-12 substr. MG1655 antibodies, 2 recombinant anti-Escherichia coli str. K-12 substr. MG1655 antibodies.

Host Species

In Labome product database, among anti-Escherichia coli str. K-12 substr. MG1655 antibodies, 89 from rabbit host, 60 from mouse host.

Antibody Conjugation

In Labome product database, among anti-Escherichia coli str. K-12 substr. MG1655 antibodies, 11 are conjugated with FITC, 19 are conjugated with biotin, 14 are conjugated with HRP.

Application

In Labome product database, among anti-Escherichia coli str. K-12 substr. MG1655 antibodies, 129 can be used for WB, 89 can be used for ELISA, 5 can be used for IHC, 7 can be used for IC, 39 can be used for IP, 4 can be used for FC, 16 can be used for EIA, 7 can be used for ChIP.

do you know?

we limit the listing of re-branded antibodies to provide our visitors with accurate information and the best experience
we manually curate antibody information from the literature to obtain a comprehensive set of well-validated antibodies.

contribute

If you are aware of any publication with knockout studies validating a monoclonal or recombinant antibody, either purchased from a supplier or developed by the author(s), please notify us through feedback.